Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Hair loss improved after removing pituitary tumor.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

MRI reveals thinner scalps and smaller hair follicles in people with androgenetic alopecia.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Women with hair loss have more androgen receptors in certain hair follicles.

Calretinin identifies the companion cell layer in human hair follicles.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

Mice with a changed Hr gene lose and regrow hair due to changes in the gene's activity.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

The removal of the adrenal tumor improved the patient's symptoms and reduced androgen levels, indicating successful surgery.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Hair loss in men might be linked to programmed cell death.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.